Dr. Daniel Blumberger, MD
Claim this profileCentre for Addiction and Mental Health
Studies Depression
Studies Major Depressive Disorder
11 reported clinical trials
21 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Blumberger, MD is currently running
Convulsive Therapies
for Depression
This trial tests how well MST and two types of ECT work in keeping depression from coming back in patients who felt better after these treatments before. It also includes patients who didn't feel better initially and are given another form of ECT. Magnetic Seizure Therapy (MST) is shown to be as effective as Electroconvulsive Therapy (ECT) in treating depression, with MST having better effects on thinking skills.
Recruiting1 award N/A15 criteria
Neurostimulation
for Mild Cognitive Impairment
More than 5 million people live with Alzheimer's dementia (AD) in North America. No effective treatment exists yet probably because by the time AD has developed it is too late to intervene. Mild Cognitive Impairment (MCI) is a clinical state that typically precedes AD. In MCI, the prefrontal cortex supports compensatory mechanisms that depend on robust synaptic plasticity and that delay progression to AD. Using a neurostimulation approach that enhances prefrontal cortical plasticity in vivo, this project aims to enhance prefrontal cortical plasticity and function in patients with MCI. If successful, this project would discover a treatment modality that enhances compensation in MCI and ultimately, prevents progression to AD.
Recruiting0 awards N/A13 criteria
More about Daniel Blumberger, MD
Clinical Trial Related7 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Daniel Blumberger, MD has experience with
- TDCS
- Mindfulness Meditation
- Subanesthetic Dose Intravenous Ketamine (KET)
- Electroconvulsive Therapy (ECT)
- Intravenous Ketamine (IV)
- Repetitive Transcranial Magnetic Stimulation
Breakdown of trials Daniel Blumberger, MD has run
Depression
Major Depressive Disorder
Bipolar Disorder
Depression, Bipolar Disorder
Acute Depression
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Blumberger, MD specialize in?
Daniel Blumberger, MD focuses on Depression and Major Depressive Disorder. In particular, much of their work with Depression has involved treating patients, or patients who are undergoing treatment.
Is Daniel Blumberger, MD currently recruiting for clinical trials?
Yes, Daniel Blumberger, MD is currently recruiting for 5 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Daniel Blumberger, MD has studied deeply?
Yes, Daniel Blumberger, MD has studied treatments such as tDCS, Mindfulness Meditation, Subanesthetic dose intravenous ketamine (KET).
What is the best way to schedule an appointment with Daniel Blumberger, MD?
Apply for one of the trials that Daniel Blumberger, MD is conducting.
What is the office address of Daniel Blumberger, MD?
The office of Daniel Blumberger, MD is located at: Centre for Addiction and Mental Health, Toronto, Ontario M6J 1H4 Canada. This is the address for their practice at the Centre for Addiction and Mental Health.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.